Accustem Sciences Profit Margin

The latest profit margin for ACUT is -1680.03% as of June 2026. That compares with -42465.67% in the prior-year period — up 96.0% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside Accustem Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACUT's profit margin moved from -42465.67% to -1680.03% — a 96.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Accustem Sciences's valuation or profitability profile.

Against Healthcare companies, ACUT currently prints -1680.03% for profit margin, while the sector average sits near 9.71%. That is roughly 17409.2% below the sector mean. Large gaps often invite a closer look at Accustem Sciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Accustem Sciences converts resources into returns. At -1680.03%, ACUT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -42465.67% in the prior-year period — up 96.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ACUT's profit margin (-1680.03%), review year-over-year change from -42465.67%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.